Lv1
28 积分 2024-10-16 加入
Plasma proteomic signature of fatty liver disease: The Rotterdam Study
1个月前
已完结
MASLD and MASH Risk: Does Losing Obesity Reverse the Metabolic Footprint
1个月前
已完结
DiabetesLiver score: A non-invasive algorithm for advanced liver fibrosis and liver-related outcomes in type 2 diabetes mellitus population
3个月前
已完结
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study
3个月前
已完结
Machine‐learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD ‐related liver fibrosis
3个月前
已完结
Referral pathways for patients with NAFLD based on non‐invasive fibrosis tests: Diagnostic accuracy and cost analysis
3个月前
已完结
Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts
10个月前
已完结
Predicting Long-Term Clinical Outcomes of Patients With Recurrent Pericarditis
1年前
已完结
Predicting Long-Term Clinical Outcomes of Patients With Recurrent Pericarditis
1年前
已完结
Cardiovascular risk assessment tools are insufficient for patients with metabolic dysfunction associated steatotic liver disease
1年前
已完结
皖公网安备34019202002308
